SIMONTE MICHAEL K
Known title: PresidentCIK: 0001286946
Associated companies
Transaction History
| DCH | ▼ Sell | Tax Withholding | 93,148 | $686K | 3/24/2023 | View on chart |
| DCH | ▼ Sell | Other | 112,918 | $0 | 3/24/2023 | View on chart |
| DCH | ▲ Buy | Grant | 72,774 | $0 | 3/24/2023 | View on chart |
| DCH | ▲ Buy | Grant | 260,459 | $0 | 3/6/2023 | View on chart |
| DCH | ▼ Sell | Tax Withholding | 115,384 | $1.1M | 3/6/2023 | View on chart |
| DCH | ▼ Sell | Tax Withholding | 90,497 | $832K | 3/6/2023 | View on chart |
| DCH | ▼ Sell | Tax Withholding | 20,998 | $167K | 3/4/2022 | View on chart |
| DCH | ▲ Buy | Grant | 121,491 | $1.1M | 2/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Dauch names new CFO, faces lower price targets from Barclays and UBS
Dauch Corporation announced a financial leadership change, appointing Nathan Iles as CFO effective December 1 to succeed Christopher May. This executive shift coincides with recent analyst actions, as both Barclays and UBS lowered their price targets to $8 while maintaining their respective ratings. The stock has experienced a significant decline since February, currently trading near its 52-week low, which has prompted discussions about potential undervaluation despite the recent downward revisions.
Dauch names new CFO, faces lower price targets from Barclays and UBS. Dauch Corporation announced a financial leadership change, appointing Nathan Iles as CFO effective December 1 to succeed Christopher May. This executive shift coincides with recent analyst actions, as both Barclays and UBS lowered their price targets to $8 while maintaining their respective ratings. The stock has experienced a significant decline since February, currently trading near its 52-week low, which has prompted discussions about potential undervaluation despite the recent downward revisions.